Ferric Cacodylate Omitted from New and Non-Official Remedies 292 Libradol 293 Helmitol Omitted from N. N. R. 295 Spirocide Not Admitted to N. N. R. 296 Digifolin-Ciba Not Admitted to N. N. R. 298 Some of Loesser’s Intravenous Solutions 299 “National Iodine Solution” Not Admitted to N. N. R. 300 Mon-Arsone Not Admitted to N. N. R. 302 Oxyl-Iodide Not Admitted to N. N. R. 304 Quassia Compound Tablets 306 Toxicide 307 Pil. Mixed Treatment (Chichester) 310 Atophan Omitted from N. N. R. 313 Urotropin Omitted from N. N. R. 316 Styptysate Not Admitted to N. N. R. 318 Lipoidal Substances (Horovitz) Not Admitted to N. N. R. 320 Yeast Preparations and Vitamin B Concentrates 321 PART II: CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY The Chemical Laboratory of the American Medical Association 322 The Work of the American Medical Association Chemical Laboratory 322 Lead in “Akoz” 328 Sodium Acetate in Warming Bottles 329 Anti-Syphilitic Compound (Sweeny) 330 “Ambrine” and Paraffin Films 330 The Stability of Iodine Ointments 337 Iodolene and the Solubility of Iodin in Liquid Petrolatum 344 American-Made Synthetic Drugs--I 344 Standardization of Commercial Bismuth Tribromphenate 348 Standardization of Procain and Examination of the Market Supply 355 Deterioration of Sodium Hypochlorite Solutions 358 Syphilodol 359 Cerelene 362 Dr. De Sanctis’ Rheumatic and Gout Pills 363 Iodex and Liquid Iodex 365 PART III: CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS Iodin in Liquid Petrolatum 367 American-Made Synthetic Drugs--II 369 Nostrums in Retrospect 379 Bell-Ans (Pa-Pay-Ans Bell) 380 Anasarcin and Anedemin 383